Freimer, M., Desai, U., Govindarajan, R., Kang, M. K., Khan, S., Khatri, B., . . . Howard, J. F. (2025). Switching to subcutaneous zilucoplan from intravenous complement component 5 inhibitors in generalised myasthenia gravis: A phase IIIb, open-label study. SAGE Publishing.
Chicago Style (17th ed.) CitationFreimer, Miriam, et al. Switching to Subcutaneous Zilucoplan from Intravenous Complement Component 5 Inhibitors in Generalised Myasthenia Gravis: A Phase IIIb, Open-label Study. SAGE Publishing, 2025.
MLA (9th ed.) CitationFreimer, Miriam, et al. Switching to Subcutaneous Zilucoplan from Intravenous Complement Component 5 Inhibitors in Generalised Myasthenia Gravis: A Phase IIIb, Open-label Study. SAGE Publishing, 2025.
Warning: These citations may not always be 100% accurate.